Evidence map›Paper›PMID 34976099›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Phytochemical Analysis Using UPLC-MS/MS Combined with Network Pharmacology Methods to Explore the Biomarkers for the Quality Control of Lingguizhugan Decoction.

Baolin Li, Shuaishuai Fan, Jingnan Hu, Yongben Ma, Yu Feng, Fengxia Wang, Xinguo Wang, Liying Niu

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Baolin LiCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0002-8917-1687
Shuaishuai FanCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0002-7163-7661
Jingnan HuCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0002-0740-2913
Yongben MaCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0003-0023-6745
Yu FengCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0002-4143-8119
Fengxia WangCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0003-1267-9383
Xinguo WangCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0003-2886-6941
Liying NiuCollege of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0002-3779-097X
Hebei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a classic TCM prescription, LGZG has been widely used in clinical prevention and treatment of heart failure, nonalcoholic fatty liver, and hyperlipidemia. However, there are few studies on chemical components in recent years, and the basis of quality evaluation is not sufficient. This study was to find the active ingredients of the Lingguizhugan decoction using UPLC-MS/MS and network pharmacology. By comparing the retention time and MS dates of the reference and self-building database, the cleavage rules of chemical composition whose mass errors are less than 1 ppm(FL less than 3 ppm) are analyzed. On this basis, a network pharmacology method was used to find biomarkers for quantitative analysis. The results show that 149 compounds were preliminaries identified or inferred, including 63 flavonoids, 30 triterpenes, 22 phenylpropanoids, 13 organic acids, 6 lactones, 5 alkaloids, 4 anthraquinones, and 6 other compounds. According to the network pharmacology results, 20 chemical constituents were selected as the biomarkers, which were determined simultaneously for the first time, including poricoic acid A, poricoic acid B, glycyrrhizic acid, glycyrrhetinic acid, liquiritin, isoliquiritin, liquiritigenin, isoliquiritin apioside, cinnamic acid, caffeic acid, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isochlorogenic acid A, B, and C, atractylenolide I, II, and III, and coumarin. The methodological results show that the linearity, stability, precision, repeatability, and recovery of the method are satisfactory. Therefore, a comprehensive quality assessment system for LGZG was established on the basis of a systematic study of chemical substances and network pharmacology, which provided an important reference for the foundation of pharmacological action and its mechanics.

Identifiers

PMID34976099
PMCPMC8716202
OpenAlexW4200591090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.